The Harvard Department of Stem Cell and Regenerative Biology (HSCRB) invites applications for Pilot Grant funding for 2021 under the NIH-funded P01 grant “Dissecting the establishment and regulation of human pluripotency” (PI Alexander Meissner).
The purpose of this funding program is to provide resources for proof-of-concept studies. These pilot grants are intended to increase our understanding of the basic biology of human pluripotent cells and their utility for translational applications.... Read more about Call for Proposals: P01 Pilot Grants 2021
HSCI scientists find that signaling defects can influence red blood cell traits
The field of genetics has made huge strides over the past couple of decades, from the first sequencing of the human genome to a growing understanding of the machinery that turns genes on and off — proteins called...
Four Harvard Stem Cell Institute (HSCI) faculty members have been awarded grants from the Chan Zuckerberg Initiative to expand the Human Cell Atlas, a global effort to map every cell in the human body. The scientists are leading projects as part of the Seed Networks for the Human Cell Atlas, whose goal is to help ensure that the first draft of the atlas is fully...
HSCI Executive Committee member Carla Kim is a recipient of the Lung Cancer Discovery Award from the American Lung Association. The award recognizes Kim’s innovative lung cancer research that has the potential to improve patient care and help save lives.
“As our nation faces COVID-19, we have not only witnessed its toll on our health, but we have also seen how air pollution,...
